USPTO serial 79356287
TISSUECYTOMETRY BY TISSUEGNOSTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TISSUECYTOMETRY BY TISSUEGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ralph Locher
Ralph Locher Lerner Greenberg Stemer, LLPP.O. Box 2480Hollywood, FL 33022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products, namely, chemicals for industrial and scientific use; biological preparations for industrial and scientific use; diagnostic reagents for scientific use; diagnostics, namely, diagnostics staining kits comprised of diagnostic reagents for scientific use, and scanning computer hardware and downloadable analysis software for tissue cytometry, for scientific use; chemical diagnostic reagents for scientific use; indicators, namely, chemicals for scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; in vitro diagnostic preparations, namely, antibody staining kits for scientific use comprised of diagnostic reagents and chemicals for scientific use; diagnostic reagents sold as a kit, the kit containing monoclonal antibodies and buffer solutions, other than for medical use; staining chemicals being fluorescence labelled monoclonal antibodies for scientific use; histological staining kits comprised of fluorescence labelled monoclonal antibodies and buffer solutions for scientific use; staining kits comprised of a combination of monoclonal antibodies relevant for specific diagnostic purposes, namely, for staining tissue sections for scientific use. | ACTIVE | — |
| 005 | Medical and veterinary diagnostic preparations for analysis of tissue sections, not limited to but including cancer tissue; diagnostic reagents for medical use; diagnostic agents being fluorescence-labelled antibody staining kits comprised of diagnostic reagents and chemicals for medical use; diagnostic reagents for in vitro use in the field of medicine; in vitro diagnostic preparations in the nature of antibody staining kits comprised of diagnostic reagents for diagnostics, for medical use; staining preparations in the nature of fluorescence-labelled staining kits comprised of diagnostic reagents and chemicals for medical use; staining kits comprised of monoclonal antibodies and buffer solutions for medical use; quantitative staining kits comprised of specific monoclonal antibodies labelled with specific sets of fluorochromes for medical use. | ACTIVE | — |
| 009 | Scientific, research, audiovisual, optical, weighing, measuring, signaling, detection, testing and inspecting apparatus and instruments, namely, microscope based digital slide scanners and tissue image cytometers; recorded and downloadable media, namely, microscopic images of tissue sections and cultures cells and organoids; downloadable and recorded computer software for management and analysis of microscopic images as well as image analysis and data visualization; computers and computer peripherals; downloadable and recorded software for evaluating medical samples for extracting information on tissue structures and cell populations relevant for understanding diseases and performing a diagnosis; downloadable and recorded software for evaluating scientific samples for visualization of cellular in-situ data; downloadable and recorded analysis software for analyzing tissue samples for the detection of specific disease status, not limited to but including cancer; downloadable and recorded analysis software for analyzing tissue samples stained with color reagents for immunohistochemistry and immunofluorescence; diagnostic apparatus for scientific use, namely, tissue image cytometers for analysis and diagnosis of human or veterinary tissue samples. | ACTIVE | — |
| 010 | Medical, surgical, therapeutic, dental and veterinary instruments and apparatus, namely, digital slide scanners; diagnostic apparatus and diagnostic measuring apparatus for medical use, namely, tissue image cytometers; analytical apparatus for histological use in the field of medicine, namely, tissue sample analyzers; analytical apparatus for medical purposes, namely, artificial intelligence-based decision support systems comprised of tissue image cytometers and sample analyzers for medical purposes, and downloadable computer software for analyzing tissue samples for detection of disease for histopathology. | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research and development services; industrial analysis and research services in the field of tissue research and histopathology; design and development of computer hardware and software; biological, clinical in the field of histology and medical research and analysis; histological medical research services; histological image analysis and tissue image cytometry development services; histological medical laboratory services; histological analysis, namely, cytometric analysis of tissue samples; consultancy services in the field of histology for scientific research and diagnostics; research and development of new products in the field of histology; research and development of microscopy-based diagnostic methods based on the analysis of tissue and cell cultures; analysis of human tissues for medical research; development of computer hardware and analytic software in the field of histology for scientific research and medical and clinical diagnostics. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TissueGnostics GmbH
- Other trademarks owned by TissueGnostics GmbH
- Other trademarks owned by TissueGnostics GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named TISSUECYTOMETRY BY TISSUEGNOSTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 19, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 19, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 8, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 8, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 22, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |